PortfoliosLab logoPortfoliosLab logo
SII vs. ABBV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SII vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sprott Inc (SII) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SII achieves a 16.59% return, which is significantly higher than ABBV's 4.43% return.


SII

1D
-3.85%
1M
-9.12%
YTD
16.59%
6M
12.81%
1Y
77.79%
3Y*
56.39%
5Y*
26.91%
10Y*

ABBV

1D
2.07%
1M
8.84%
YTD
4.43%
6M
4.29%
1Y
31.92%
3Y*
24.36%
5Y*
19.80%
10Y*
19.47%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SII vs. ABBV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
SII
Sprott Inc
16.59%137.17%27.39%5.00%-24.09%59.43%-19.45%
ABBV
AbbVie Inc.
4.43%33.08%18.86%-0.23%24.01%32.43%14.36%

Correlation

The correlation between SII and ABBV is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.04

Correlation (3Y)
Calculated over the trailing 3-year period

0.03

Correlation (5Y)
Calculated over the trailing 5-year period

0.05

Correlation (All Time)
Calculated using the full available price history since Jun 29, 2020

0.07

The correlation between SII and ABBV shifts across timeframes, from -0.04 (1 year) to 0.07 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

SII:

$2.11B

ABBV:

$416.46B

EPS

SII:

$3.53

ABBV:

$2.05

PE Ratio

SII:

32.19

ABBV:

114.38

PS Ratio

SII:

7.21

ABBV:

6.63

PB Ratio

SII:

5.52

ABBV:

15.14

Total Revenue (TTM)

SII:

$377.77M

ABBV:

$62.82B

Gross Profit (TTM)

SII:

$278.09M

ABBV:

$46.15B

EBITDA (TTM)

SII:

$120.39M

ABBV:

$17.96B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SII vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SII
SII Risk / Return Rank: 8181
Overall Rank
SII Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
SII Sortino Ratio Rank: 8080
Sortino Ratio Rank
SII Omega Ratio Rank: 8080
Omega Ratio Rank
SII Calmar Ratio Rank: 7979
Calmar Ratio Rank
SII Martin Ratio Rank: 8181
Martin Ratio Rank

ABBV
ABBV Risk / Return Rank: 7575
Overall Rank
ABBV Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 7575
Sortino Ratio Rank
ABBV Omega Ratio Rank: 7373
Omega Ratio Rank
ABBV Calmar Ratio Rank: 7474
Calmar Ratio Rank
ABBV Martin Ratio Rank: 7373
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SII vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sprott Inc (SII) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SIIABBVDifference
Sharpe ratioReturn per unit of total volatility

+0.36

Sortino ratioReturn per unit of downside risk

+0.38

Omega ratioGain probability vs. loss probability

1.29

1.24

+0.05

Calmar ratioReturn relative to maximum drawdown

2.44

1.85

+0.59

Martin ratioReturn relative to average drawdown

6.38

4.11

+2.27

SII vs. ABBV - Sharpe Ratio Comparison

The current SII Sharpe Ratio is 1.63, which is comparable to the ABBV Sharpe Ratio of 1.27. The chart below compares the historical Sharpe Ratios of SII and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SII vs. ABBV - Drawdown Comparison

The maximum SII drawdown since its inception was -47.81%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for SII and ABBV.


Loading charts...

Drawdown Indicators


SIIABBVDifference

Max Drawdown

Largest peak-to-trough decline

-47.81%

-45.09%

-2.72%

Max Drawdown (1Y)

Largest decline over 1 year

-32.00%

-17.32%

-14.68%

Max Drawdown (3Y)

Largest decline over 3 years

-32.00%

-20.74%

-11.26%

Max Drawdown (5Y)

Largest decline over 5 years

-47.81%

-21.92%

-25.89%

Max Drawdown (10Y)

Largest decline over 10 years

-45.09%

Current Drawdown

Current decline from peak

-31.56%

-1.66%

-29.90%

Average Drawdown

Average peak-to-trough decline

-21.10%

-10.70%

-10.40%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.23%

7.78%

+4.45%

Volatility

SII vs. ABBV - Volatility Comparison

Sprott Inc (SII) has a higher volatility of 15.17% compared to AbbVie Inc. (ABBV) at 9.26%. This indicates that SII's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SIIABBVDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.17%

9.26%

+5.91%

Volatility (6M)

Calculated over the trailing 6-month period

41.36%

19.11%

+22.25%

Volatility (1Y)

Calculated over the trailing 1-year period

48.01%

25.23%

+22.78%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

37.90%

23.12%

+14.78%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

37.86%

25.83%

+12.03%

Dividends

SII vs. ABBV - Dividend Comparison

SII's dividend yield for the trailing twelve months is around 1.32%, less than ABBV's 2.87% yield.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
2.87%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
SII
Sprott Inc
1.32%1.33%2.49%2.95%3.00%2.22%1.66%0.00%0.00%0.00%0.00%0.00%

Financials

SII vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Sprott Inc and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
143.35M
15.00B
(SII) Total Revenue
(ABBV) Total Revenue
Values in USD except per share items

SII vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between Sprott Inc and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%90.0%20222023202420252026
91.6%
83.5%
Portfolio components
SII - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sprott Inc reported a gross profit of 131.24M and revenue of 143.35M. Therefore, the gross margin over that period was 91.6%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.

SII - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sprott Inc reported an operating income of 41.26M and revenue of 143.35M, resulting in an operating margin of 28.8%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.

SII - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sprott Inc reported a net income of 28.81M and revenue of 143.35M, resulting in a net margin of 20.1%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.


Frequently Asked Questions


SII and ABBV have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SII has higher volatility (15.17%) compared to ABBV (9.26%). In terms of maximum drawdown, SII dropped -47.81% vs ABBV's -45.09%.

SII currently has the higher Sharpe Ratio (1.63 vs 1.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SII and ABBV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer